Niche iPSC focus LAgen Laboratories specializes in distributing induced pluripotent stem cells (iPSCs) and differentiating them into retinal pigment epithelial (RPE) cells, presenting a targeted opportunity to upsell advanced iPSC-derived products and differentiation services to research labs and biotech developers.

Academic & industry reach Current offerings are tailored for both academic and industrial researchers, suggesting sales potential through university core facilities, collaboration programs, and contract research arrangements that require specialized iPSC and RPE workflows.

Low revenue but strategic niche With annual revenue under one million, there is room to expand through broader distribution of culture media, supplements, and antibodies for iPSC-derived RPE cells, as well as bundled product–service packages.

Economic buyer cues Similar companies operate at large scales; LAgen can position as a specialized supplier for smaller labs needing cost-effective, high-quality iPSC and RPE components, offering competitive pricing, quick onboarding, and technical support.

Tech-enabled sales The existing tech stack (cookie compliance, e-commerce capabilities, marketing automation) can be leveraged to run targeted campaigns, seed trials, and repeat orders with streamlined purchasing and robust support for researchers transitioning to RPE workflows.